Differential Incidence of Contrast-Associated Acute Kidney Injury: Comparing Intravenous and Intraarterial Contrast Administration.
Contrast-associated nephropathy
Intravenous contrast
Prevention
Journal
Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969
Informations de publication
Date de publication:
16 Jul 2024
16 Jul 2024
Historique:
accepted:
17
06
2024
medline:
16
7
2024
pubmed:
16
7
2024
entrez:
16
7
2024
Statut:
aheadofprint
Résumé
Contrast-associated acute kidney injury (CA-AKI) remains a significant concern in diagnostic and invasive procedures, particularly in the context of iodinated contrast material administration. The traditional definition of CA-AKI, based on serum creatinine elevation following contrast exposure, may not accurately capture its multifactorial nature. Studies have provided new insights into the differential incidence of CA-AKI between intravenous and intraarterial contrast administration, emphasizing the importance of tailored preventative strategies for high-risk procedures. This higher risk may arise from two proposed mechanisms: one implicating free radical formation leading to cytotoxicity and apoptosis in renal cells and another suggesting that contrast media alter renal hemodynamics, particularly in the outer medulla, by constricting the vasa recta and reducing medullary flow. Advances in technology and patient care, including contemporary use of low-osmolar contrast agents and hydration protocols, mitigate CA-AKI risk. Diagnostic and invasive procedures should not be avoided solely due to concerns about renal dysfunction if the patient is likely to benefit clinically.
Identifiants
pubmed: 39012549
doi: 10.1007/s11886-024-02083-w
pii: 10.1007/s11886-024-02083-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Davenport MS, Cohan RH, Ellis JH. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. AJR Am J Roentgenol. 2015;204(6):1174–81.
pubmed: 25730301
doi: 10.2214/AJR.14.14259
Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2020;2(1):85–93.
Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced nephropathy. Heart Views. 2013;14(3):106–16.
pubmed: 24696755
pmcid: 3969626
doi: 10.4103/1995-705X.125926
Ad-hoc working group of E, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263-72.
Budano C, Levis M, D’Amico M, Usmiani T, Fava A, Sbarra P, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J. 2011;161(5):963–71.
pubmed: 21570530
doi: 10.1016/j.ahj.2011.02.004
Everson M, Sukcharoen K, Milner Q. Contrast-associated acute kidney injury. BJA Educ. 2020;20(12):417–23.
pubmed: 33456926
pmcid: 7808023
doi: 10.1016/j.bjae.2020.07.006
Mehran R, Owen R, Chiarito M, Baber U, Sartori S, Cao D, et al. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet. 2021;398(10315):1974–83.
pubmed: 34793743
doi: 10.1016/S0140-6736(21)02326-6
Davenport MS, Cohan RH, Khalatbari S, Ellis JH. The challenges in assessing contrast-induced nephropathy: where are we now? AJR Am J Roentgenol. 2014;202(4):784–9.
pubmed: 24660707
doi: 10.2214/AJR.13.11369
McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH, et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013;267(1):119–28.
pubmed: 23319662
doi: 10.1148/radiol.12121460
McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A):5K-13K.
pubmed: 16949375
doi: 10.1016/j.amjcard.2006.01.019
Gupta S, Motwani SS, Seitter RH, Wang W, Mu Y, Chute DF, et al. Development and validation of a risk model for predicting contrast-associated acute kidney injury in patients with cancer: evaluation in over 46,000 CT examinations. AJR Am J Roentgenol. 2023;221(4):486–501.
pubmed: 37195792
doi: 10.2214/AJR.23.29139
Park S, Kim MH, Kang E, Park S, Jo HA, Lee H, et al. Contrast-induced nephropathy after computed tomography in stable ckd patients with proper prophylaxis: 8-year experience of outpatient prophylaxis program. Medicine (Baltimore). 2016;95(18):e3560.
pubmed: 27149474
doi: 10.1097/MD.0000000000003560
Lakhal K, Ehrmann S, Chaari A, Laissy JP, Regnier B, Wolff M, et al. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011;26(6):593–9.
pubmed: 21737245
doi: 10.1016/j.jcrc.2011.05.010
Su TH, Hsieh CH, Chan YL, Wong YC, Kuo CF, Li CH, et al. Intravenous CT contrast media and acute kidney injury: a multicenter emergency department-based study. Radiology. 2021;301(3):571–81.
Kim SM, Cha RH, Lee JP, Kim DK, Oh KH, Joo KW, et al. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report. Am J Kidney Dis. 2010;55(6):1018–25.
pubmed: 20097462
doi: 10.1053/j.ajkd.2009.10.057
Hsu RK, Hsu CY. The role of acute kidney injury in chronic kidney disease. Semin Nephrol. 2016;36(4):283–92.
pubmed: 27475659
pmcid: 4979984
doi: 10.1016/j.semnephrol.2016.05.005
Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9.
pubmed: 24456715
pmcid: 4122507
doi: 10.1016/j.jcin.2013.06.016
Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010;122(23):2451–5.
pubmed: 21135373
doi: 10.1161/CIRCULATIONAHA.110.953851
Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007;22(3):819–26.
pubmed: 17090607
doi: 10.1093/ndt/gfl636
Garcia S, Ko B, Adabag S. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations. Ann Thorac Surg. 2012;94(3):772–6.
pubmed: 22835553
doi: 10.1016/j.athoracsur.2012.04.089
Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, et al. Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit? J Am Heart Assoc. 2017;6(6):24.
doi: 10.1161/JAHA.117.005715
Jain T, Shah S, Shah J, Jacobsen G, Khandelwal A. Contrast-induced nephropathy in STEMI patients with and without chronic kidney disease. Crit. 2018;17(1):25–31.
Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, et al. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Heart Vessels. 2017;32(1):22–9.
pubmed: 27106917
doi: 10.1007/s00380-016-0836-8
Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006;67(2):227–35.
pubmed: 16400673
doi: 10.1002/ccd.20598
Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Rosen S, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int. 1995;47(6):1806–10.
pubmed: 7543962
doi: 10.1038/ki.1995.249
Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol. 2002;37(8):428–34.
pubmed: 12138358
doi: 10.1097/00004424-200208000-00003
Katholi RE, Woods WT Jr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32(1):64–71.
pubmed: 9669426
doi: 10.1053/ajkd.1998.v32.pm9669426
Erley CM, Heyne N, Rossmeier S, Vogel T, Risler T, Osswald H. Adenosine and extracellular volume in radiocontrast media-induced nephropathy. Kidney Int Suppl. 1998;67:S192–4.
pubmed: 9736287
doi: 10.1046/j.1523-1755.1998.06744.x
Yao K, Heyne N, Erley CM, Risler T, Osswald H. The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency. Eur J Pharmacol. 2001;414(1):99–104.
pubmed: 11231000
doi: 10.1016/S0014-2999(01)00764-6
Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95(1):13–9.
pubmed: 15619387
doi: 10.1016/j.amjcard.2004.08.056
Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc. 2009;84(2):170–9.
pubmed: 19181651
pmcid: 2664588
doi: 10.4065/84.2.170
Zhang W, Zhang J, Yang B, Wu K, Lin H, Wang Y, et al. Effectiveness of oral hydration in preventing contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention: a pairwise and network meta-analysis. Coron Artery Dis. 2018;29(4):286–93.
pubmed: 29381498
doi: 10.1097/MCA.0000000000000607
Liu Y, Tan N, Huo Y, Chen SQ, Liu J, Wang Y, et al. Simplified rapid hydration prevents contrast-associated acute kidney injury among CKD Patients undergoing coronary angiography. JACC Cardiovasc Interv. 2023;16(12):1503–13.
Xie W, Zhou Y, Liao Z, Lin B. Effect of oral hydration on contrast-induced acute kidney injury among patients after primary percutaneous coronary intervention. Cardiorenal med. 2021;11(5–6):243–51.
pubmed: 34823253
doi: 10.1159/000520088
Hu MJ, Luo EF, Tang CC, Wang L, Zhang QG, Gong JB. Meta-analysis of the effects of furosemide combined with hydration therapy on contrast-induced acute kidney injury after coronary intervention. Eur Rev Med Pharmacol Sci. 2021;25(14):4729–37.
pubmed: 34337720
Putzu A, BoscoloBerto M, Belletti A, Pasotti E, Cassina T, Moccetti T, et al. Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: a systematic review and meta-analysis of randomized trials. JACC Cardiovasc Interv. 2017;10(4):355–63.
pubmed: 28231903
doi: 10.1016/j.jcin.2016.11.006
Komiyama K, Ashikaga T, Inagaki D, Miyabe T, Arai M, Yoshida K, et al. Sodium bicarbonate-ascorbic acid combination for prevention of contrast-induced nephropathy in chronic kidney disease patients undergoing catheterization. Circ J. 2017;81(2):235–40.
pubmed: 28003574
doi: 10.1253/circj.CJ-16-0921
Maioli M, Toso A, Leoncini M, Micheletti C, Bellandi F. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial. Circ. 2011;4(5):456–62.
Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). J Am Coll Cardiol. 2014;63(1):71–9.
pubmed: 24076283
doi: 10.1016/j.jacc.2013.04.105
Magner K, Ilin JV, Clark EG, Kong JWY, Davis A, Hiremath S. Meta-analytic techniques to assess the association between N-acetylcysteine and acute kidney injury after contrast administration: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(7):e2220671.
pubmed: 35788669
pmcid: 9257561
doi: 10.1001/jamanetworkopen.2022.20671
Eng J, Wilson RF, Subramaniam RM, Zhang A, Suarez-Cuervo C, Turban S, et al. Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med. 2016;164(6):417–24.
pubmed: 26830055
doi: 10.7326/M15-1402
Sacha J, Gierlotka M, Feusette P, Dudek D. Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review. Postepy Kardiol Interwencyjnej. 2019;15(2):127–36.
pubmed: 31497044
pmcid: 6727230
Kumar P, Jino B, Roy S, Shafeeq A, Rajendran M. Absolute zero-contrast percutaneous coronary intervention under intravascular ultrasound guidance in chronic kidney disease patients - from despair to hope? Int J Cardiol Heart Vasc. 2022;40:101052.
pubmed: 35601526
pmcid: 9120254
Hatem R, Finn MT, Riley RF, Mathur M, Lombardi WL, Ali ZA, et al. Zero contrast retrograde chronic total occlusions percutaneous coronary intervention: a case series. Eur Heart J Case Rep. 2018;2(2):1–5.
pubmed: 30370403
HeshmatzadehBehzadi A, Amoozgar B, Jain S, Velasco N, Zahid U, Abbasi H, et al. Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: a systematic review and meta-analysis (PRISMA). Medicine (Baltimore). 2021;100(10):e24603.
doi: 10.1097/MD.0000000000024603
Ikizler TA, Parikh CR, Himmelfarb J, Chinchilli VM, Liu KD, Coca SG, et al. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021;99(2):456–65.
pubmed: 32707221
doi: 10.1016/j.kint.2020.06.032
Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115(25):3189–96.
pubmed: 17562951
doi: 10.1161/CIRCULATIONAHA.106.671644